UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence

Postgraduate medicine, 2019-05, Vol.131 (4), p.251-260

Davidson, Jaime A

2019

Volltextzugriff (PDF)

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Circulation (New York, N.Y.), 2014-10, Vol.130 (18), p.1579-1588

2014

Volltextzugriff (PDF)

The Increasing Role of Primary Care Physicians in Caring for Patients With Type 2 Diabetes Mellitus

Mayo Clinic proceedings, 2010-12, Vol.85 (12), p.S3-S4

Davidson, Jaime A., MD

2010

Volltextzugriff (PDF)

The placement of DPP-4 inhibitors in clinical practice recommendations for the treatment of type 2 diabetes

Endocrine practice, 2013-11, Vol.19 (6), p.1050

Davidson, Jaime A

2013

Volltextzugriff (PDF)

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

Endocrine practice, 2009-09, Vol.15 (6), p.540-559

2009

Volltextzugriff (PDF)

The status of diabetes and its complications in Latin-American population: A review article

Diabetes research and clinical practice, 2020-10, Vol.168, p.108274-108274, Article 108274

2020

Volltextzugriff (PDF)

Comment on Riddle et al. Diabetes Care Editors’ Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Diabetes Care 2019;42:1136–1146

Diabetes care, 2019-11, Vol.42 (11), p.e183-e183

2019

Volltextzugriff (PDF)

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Endocrine practice, 2015-04, Vol.21 Suppl 1, p.1-87

2015

Volltextzugriff (PDF)

Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview

Advances in therapy, 2017-01, Vol.34 (1), p.41-59

2017

Volltextzugriff (PDF)

Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes

Clinical therapeutics, 2016-03, Vol.38 (3), p.582-594

2016

Volltextzugriff (PDF)

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial

Diabetes care, 2015-04, Vol.38 (4), p.696-705

2015

Volltextzugriff (PDF)

Safety of sodium–glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations

Journal of diabetes investigation, 2023-02, Vol.14 (2), p.167-182

2023

Volltextzugriff (PDF)

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan

Endocrine practice, 2011-03, Vol.17 Suppl 2, p.1-53

2011

Volltextzugriff (PDF)

Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors

Mayo Clinic proceedings, 2010-12, Vol.85 (12), p.S27-S37

Davidson, Jaime A., MD

2010

Volltextzugriff (PDF)

Cardiovascular disease in diabetes mellitus: risk factors and medical therapy

Endocrinology and metabolism clinics of North America, 2014-03, Vol.43 (1), p.25-40

2014

Volltextzugriff (PDF)

Effects of once‐weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials

Diabetes, obesity & metabolism, 2017-03, Vol.19 (3), p.436-441

2017

Volltextzugriff (PDF)

Sodium Glucose Co-Transporter 2 Inhibitors and Their Mechanism for Improving Glycemia in Patients with Type 2 Diabetes

Postgraduate medicine, 2014-10, Vol.126 (6), p.33-48

2014

Volltextzugriff (PDF)

Differential effects of prandial and non-prandial GLP-1 receptor agonists in type 2 diabetes therapy

Postgraduate medicine, 2015-01, Vol.127 (8), p.827-841

Davidson, Jaime A.

2015

Volltextzugriff (PDF)

Mild renal impairment and the efficacy and safety of liraglutide

Endocrine practice, 2011-05, Vol.17 (3), p.345-355

2011

Volltextzugriff (PDF)

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c

The American journal of medicine, 2016-03, Vol.129 (3), p.340.e1-340.e8

2016

Volltextzugriff (PDF)

Advances in therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors

Cleveland Clinic journal of medicine, 2009-12, Vol.76 Suppl 5 (12 suppl 5), p.S28-S38

Davidson, Jaime A

2009

Volltextzugriff (PDF)

New-onset diabetes after transplantation 2003 International Consensus Guidelines: An endocrinologist's view

Diabetes care, 2004-03, Vol.27 (3), p.805-812

2004

Volltextzugriff (PDF)

Dapagliflozin suppresses glucagon signaling in rodent models of diabetes

Proceedings of the National Academy of Sciences - PNAS, 2017-06, Vol.114 (25), p.6611-6616

2017

Volltextzugriff (PDF)

CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN

Endocrine practice, 2016-06, Vol.22 (6), p.726-735

2016

Volltextzugriff (PDF)

TRANSCULTURAL DIABETES CARE IN THE UNITED STATES - A POSITION STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS

Endocrine practice, 2019-07, Vol.25 (7), p.729-765

2019

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(204)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Humans
(128)
Life Sciences & Biomedicine
(119)
Male
(57)
Endocrinology & Metabolism
(54)
Female
(54)
Diabetes Mellitus, Type 2 - Drug Therapy
(53)
Hypoglycemic Agents - Therapeutic Use
(43)
Middle Aged
(40)
Diabetes
(38)
Aged
(33)
Adult
(31)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Type 2 Diabetes
(25)
Risk Factors
(24)
Treatment Outcome
(24)
General & Internal Medicine
(21)
Hypoglycemic Agents - Administration & Dosage
(21)
Hypoglycemic Agents - Adverse Effects
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

The Increasing Role of Primary Care Physicians in Caring for Patients With Type 2 Diabetes Mellitus

The placement of DPP-4 inhibitors in clinical practice recommendations for the treatment of type 2 diabetes

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

The status of diabetes and its complications in Latin-American population: A review article

Comment on Riddle et al. Diabetes Care Editors’ Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Diabetes Care 2019;42:1136–1146

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview

Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial

Safety of sodium–glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan

Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors

Cardiovascular disease in diabetes mellitus: risk factors and medical therapy

Effects of once‐weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials

Sodium Glucose Co-Transporter 2 Inhibitors and Their Mechanism for Improving Glycemia in Patients with Type 2 Diabetes

Differential effects of prandial and non-prandial GLP-1 receptor agonists in type 2 diabetes therapy

Mild renal impairment and the efficacy and safety of liraglutide

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c

Advances in therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors

New-onset diabetes after transplantation 2003 International Consensus Guidelines: An endocrinologist's view

Dapagliflozin suppresses glucagon signaling in rodent models of diabetes

CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN

TRANSCULTURAL DIABETES CARE IN THE UNITED STATES - A POSITION STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS

Suchergebnisse filtern